Loading...

Loading...

Close Customer Services Vital for Progress in the "New Normal"
By Peter Appleby - Tue, 09/08/2020 - 12:03
Ramboll Mexico Managing Director Arturo Rodríguez discusses the future of environmental and industrial safety in the "new normal".
https://mexicobusiness.news/tag/arturo-rodriguez
More Health
Mexico’s Opportunities and Challenges as a Research Hub
By Miriam Bello - Mon, 08/10/2020 - 14:29
What is Mexico’s potential to become a research hub and how can the country successfully capitalize on this opportunity?
Social Compliance Across the Value Chain
By - Wed, 01/22/2020 - 15:08
Ramboll's Managing Director advises its clients to put social and environmental considerations at the center of their planning.
Pharmacoeconomic Studies Guarantee Better Access to Medicines
By - Sat, 01/26/2019 - 14:20
INFINITE is a 100 percent Mexican institution with 15 years of experience in clinical research in Latin America.
Social Infrastructure, A Path To Mining Prosperity
By - Mon, 10/22/2018 - 16:33
Minerals are embedded in most aspects of human life. This ensures a steady demand, making mining one of the wealthiest industries in the world. But with mines often located in poorly-developed areas...
Mexican CRO Sees Future in Pharmacovigilance
By - Wed, 09/05/2018 - 16:41
“As ACROM, we participated in March 2017 in a group of leaders in charge of optimizing response times for the approval of clinical trials.”
Taking Mexico to the Top 10 in Clinical Research
By - Thu, 09/07/2017 - 11:38
Mexico Health Summit 2017: Taking Mexico to the Top 10 in Clinical Research panel highlights
What Must Mexico Do to Become a Clinical Research Hub?
By - Wed, 09/06/2017 - 12:21
Mexico Health Review spoke with three CROs about the best strategies that can help Mexico become an international hub for clinical research.
Leading the Clinical Research Charge
By - Wed, 09/06/2017 - 09:28
Infinite Clinical Research (ICR) is a Mexican CRO that has 15 years of experience in clinical trials in Mexico and in Latin America.
Clinical Trial Investment Dependent on Stakeholder Education
By - Wed, 09/07/2016 - 12:44
US$28 billion is invested globally clinical trials, of which Mexico only receives US$200 million or 1 percent of clinical trials